B. Riley Wealth Advisors Inc. decreased its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE – Free Report) by 23.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 65,017 shares of the company’s stock after selling 20,153 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Global Medical REIT were worth $735,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in GMRE. AJOVista LLC acquired a new stake in Global Medical REIT in the fourth quarter valued at about $54,000. Quadrant Capital Group LLC lifted its position in Global Medical REIT by 41.5% in the fourth quarter. Quadrant Capital Group LLC now owns 5,679 shares of the company’s stock valued at $63,000 after purchasing an additional 1,666 shares during the period. Creekmur Asset Management LLC acquired a new stake in Global Medical REIT in the fourth quarter valued at about $92,000. New York Life Investment Management LLC acquired a new stake in Global Medical REIT in the fourth quarter valued at about $115,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Global Medical REIT by 19.2% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,110 shares of the company’s stock valued at $146,000 after purchasing an additional 2,114 shares during the period. Institutional investors and hedge funds own 57.52% of the company’s stock.
Global Medical REIT Trading Down 4.8 %
Shares of Global Medical REIT stock opened at $8.81 on Friday. Global Medical REIT Inc. has a 12-month low of $7.98 and a 12-month high of $11.59. The company has a current ratio of 0.22, a quick ratio of 0.22 and a debt-to-equity ratio of 1.14. The stock has a market cap of $577.50 million, a PE ratio of 38.28, a price-to-earnings-growth ratio of 1.28 and a beta of 1.21. The company has a 50-day moving average of $8.73 and a two-hundred day moving average of $9.41.
Global Medical REIT Dividend Announcement
Analysts Set New Price Targets
A number of equities research analysts recently commented on GMRE shares. StockNews.com downgraded shares of Global Medical REIT from a “buy” rating to a “hold” rating in a research report on Wednesday, February 28th. B. Riley reduced their price objective on shares of Global Medical REIT from $11.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, May 13th.
Get Our Latest Stock Analysis on Global Medical REIT
About Global Medical REIT
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Featured Articles
- Five stocks we like better than Global Medical REIT
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Sarepta Therapeutics Stock Soars on FDA Approval
- Investing in Travel Stocks Benefits
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- Insider Trades May Not Tell You What You Think
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMRE – Free Report).
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.